I should rephrase the above a little... they've never come up against a phase 3 trial of this magnitude before.. let alone back-to-back ones due early and mid 2020.
We already had one successful phase 3 trial, which is up for product approval later this year.. but the size of the aGVHD market is like a drop in the ocean compared to CLBP and CHF.
MSB Trading - 2020, page-737
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.040(3.69%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.12 | $1.02 | $15.82M | 15.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 28882 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 14725 | 4 |
View Market Depth
| Last trade - 10.40am 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.04 |
Change
-0.040 ( 3.61 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.12 | $1.02 | 1446250 | ||
| Last updated 11.00am 30/04/2024 ? | |||||
| MSB (ASX) Chart |